Literature DB >> 12835219

Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics.

Jean-Luc Monin1, Jean-Paul Quéré, Mehran Monchi, Hélène Petit, Serge Baleynaud, Christophe Chauvel, Camélia Pop, Patrick Ohlmann, Claude Lelguen, Patrick Dehant, Christophe Tribouilloy, Pascal Guéret.   

Abstract

BACKGROUND: The prognostic value of dobutamine stress hemodynamic data in the setting of low-gradient aortic stenosis has been addressed in small, single-center studies. Larger studies are needed to define the criteria for selecting the patients who will benefit from valve replacement. METHODS AND
RESULTS: Six centers prospectively enrolled 136 patients with aortic stenosis (96 men; median age, 72 years [range, 65 to 77 years]; median aortic valve area, 0.7 cm2 [range, 0.6 to 0.8]; mean transaortic gradient, 29 mm Hg [range, 23 to 34 mm Hg]; cardiac index, 2.11 L x min(-1) x m(-2) [range, 1.75 to 2.55 L x min(-1) x m(-2)]). Left ventricular contractile reserve on the dobutamine stress Doppler study was present in 92 patients (group I) and absent in 44 patients (group II). Operative mortality was 5% (3 of 64 patients) in group I compared with 32% (10 of 31 patients) in group II (P=0.0002). Predictors for operative mortality were the lack of contractile reserve (odds ratio, 10.9; 95% confidence interval [CI], 2.6 to 43.4; P=0.001) and a mean transaortic gradient < or =20 mm Hg (odds ratio, 4.7; 95% CI, 1.1 to 21.0; P=0.04). Predictors for long-term survival were valve replacement (hazard ratio, 0.30; 95% CI, 0.17 to 0.53; P=0.001) and left ventricular contractile reserve (hazard ratio, 0.40; 95% CI, 0.23 to 0.69; P=0.001).
CONCLUSIONS: In the setting of low-gradient aortic stenosis, surgery seems beneficial for most of the patients with left ventricular contractile reserve. In contrast, the postoperative outcome of patients without reserve is compromised by a high operative mortality. Thus, dobutamine stress Doppler hemodynamics may be factored into the risk-benefit analysis for each patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835219     DOI: 10.1161/01.CIR.0000079171.43055.46

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  85 in total

1.  What influences the outcome of valve replacement in critical aortic stenosis?

Authors:  H Baumgartner
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

Review 2.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 3.  Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing.

Authors:  J Bermejo; R Yotti
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 4.  Low "gradient", low flow aortic stenosis.

Authors:  John Chambers
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

Review 5.  Degenerative aortic stenosis.

Authors:  Radhakrishnan Ramaraj; Vincent L Sorrell
Journal:  BMJ       Date:  2008-03-08

Review 6.  Stress testing in valve disease.

Authors:  Luc A Piérard; Patrizio Lancellotti
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 7.  Workup and Management of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis.

Authors:  Mohamed-Salah Annabi; Marine Clisson; Marie-Annick Clavel; Philippe Pibarot
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-05-02

Review 8.  Principles of transthoracic echocardiographic evaluation.

Authors:  Anita C Boyd; Nelson B Schiller; Liza Thomas
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

9.  Asymptomatic severe aortic stenosis with left ventricular dysfunction: watchful waiting or valve replacement?

Authors:  Larry E Miller; Valerie M Miller; Larry D Acers
Journal:  Clin Med Res       Date:  2013-04-11

Review 10.  Low-gradient aortic stenosis.

Authors:  Marie-Annick Clavel; Julien Magne; Philippe Pibarot
Journal:  Eur Heart J       Date:  2016-03-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.